Your session is about to expire
← Back to Search
Patients treated with Prednisone for Liver Cancer
Study Summary
This trial involves patients taking Prednisone for three days before starting Radiation Therapy and continuing to take 60 mg/day during the first three sessions of therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 3 trial • 854 Patients • NCT00003389Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are participants currently being enrolled in this clinical trial?
"As per the details outlined on clinicaltrials.gov, this investigation is actively pursuing individuals to participate. The study was initially shared on 2/1/2024 and underwent its latest update on the same date."
What is the total number of individuals involved as participants in this medical study?
"Indeed, the details on clinicaltrials.gov imply that this medical investigation is actively seeking candidates. The trial was initially published on February 1st, 2024, and has been recently revised on the same date. A total of 20 participants are sought from a single designated site."
What is the level of safety for individuals receiving treatment with Prednisone?
"Our team at Power assesses the safety of patients treated with prednisone as a 2 on our scale, reflecting data supporting safety but not efficacy in this Phase 2 trial."
Share this study with friends
Copy Link
Messenger